Malaysian Genomics Sees Rise in Profit Margins for 1Q

PETALING JAYA, Malaysia, Nov 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported a revenue of RM3.81 million for the first quarter ended 30 September 2022 (1Q 2023) versus a revenue of RM9.32 million in 1Q 2022, as the Group refocuses on immunotherapy […]

Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference

SYDNEY, AU, Sep 15, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell & Gene Therapy World Asia 2022 conference. Novotech has extensive experience in cell & gene therapy clinical trials across Asia Pacific. […]

Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia

PETALING JAYA, Malaysia, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. Azri Azerai, Executive Director of Malaysian Genomics […]

Weichai Power Announces 2021 Annual Results

HONG KONG, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Weichai Power Company Limited (“Weichai Power” or the “Company”, SEHK stock code: 2338.HK; Shenzhen Stock Exchange stock code: 000338.SZ) announced its annual results for the year ended 31 December 2021 (the “year”) on 30th March, prepared in accordance with PRC accounting standards. Steady growth […]

Honda to Install Stationary Fuel Cell Power Station on California Campus as First Step Toward Commercialization of Zero-Emission Backup Power Generation

Torrance, Calif., Mar 15, 2022 – (JCN Newswire via SEAPRWire.com) – Honda today announced plans to install a stationary fuel cell power station on its corporate campus in Torrance, Calif. by early 2023. The station will serve as a proof of concept for the future commercialization of a power generation unit for use as a […]

Fujitsu and Tokyo Medical and Dental University leverage world’s fastest supercomputer and AI technology for scientific discovery to shed light on drug resistance in cancer treatment

TOKYO, Mar 7, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover new causal mechanisms of drug resistance in cancer treatments from clinical data. Leveraging the world’s fastest supercomputer “Fugaku,”(1) the new technology enables high-speed calculation of 20,000 […]

Technological Revolution and Industrial Transformation, Weichai Power Releases the World’s First Diesel Engine with a Base Engine Thermal Efficiency of 51.09%, along with Major Hydrogen Energy Technology Achievements

HONG KONG, Jan 13, 2022 – (ACN Newswire via SEAPRWire.com) – At 9:00 am on January 8, 2022, Weichai Power (Stock codes: 2338.HK; 000338.SZ) released the world’s first diesel engine with a base engine thermal efficiency of 51.09% and major achievements in hydrogen technology achievements. Tan Xuguang, CPC Secretary and Chairman of Shandong Heavy Industry […]

European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) as First-Line Treatment for Adult Patients With Advanced Renal Cell Carcinoma

TOKYO and KENILWORTH, N.J., Nov 29, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the European Commission has approved the combination of LENVIMA (KISPLYX in the European Union [EU] for the treatment of advanced renal […]

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Two Different Types of Cancer

TOKYO and KENILWORTH, N.J., Oct 18, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted positive opinions recommending approval of […]

Shanghai Announced: 100 Hydrogen Fueling Stations Will Be Established and the Industry Scale Will Be 100 Billion Yuan

Shanghai, China / TickerInsider / August 27, 2021 / – In the evening of August 26, Shanghai Economic and Information Commission officially announced that the Shanghai government plans to build close to 100 hydrogen fuel refueling stations, forming an output scale of nearly 100 billion yuan and promoting close to 10,000 fuel cell vehicles. Meijin Energy […]

Toyota Moves Closer to Production with Next Generation Fuel Cell Electric Technology for Zero-Emissions Heavy Duty Trucks

Texas, Dec 11, 2020 – (JCN Newswire) – Toyota’s next generation fuel cell electric technology is now powering a new set of Class 8 heavy-duty trucks. Using the same fuel cell system as the all-new 2021 Mirai sedan that goes on sale this month, the engineers at Toyota Motor North America Research and Development have […]

Toyota and Hino Launch Initiative with Seven-Eleven, FamilyMart, and Lawson to Introduce Light-Duty Fuel Cell Electric Trucks

TOKYO, Dec 8, 2020 – (JCN Newswire) – Toyota Motor Corporation and Hino Motors, Ltd., together with Seven-Eleven Japan Co., Ltd., FamilyMart Co., Ltd., and Lawson, Inc., have agreed to jointly consider introducing light-duty fuel cell electric trucks (light-duty FCETs), and to establish an environment for its widespread use in the future, targeting the realization […]

BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine

Vancouver, BC, Nov 11, 2020 – (ACN Newswire) – BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (“BioVaxys”) is pleased to announce that results from its preclinical animal study (also known as the “murine model study”) of BVX-0320, its Covid-19 vaccine candidate, show that the vaccine elicits a positive immune response against the SARS-CoV-2 s-spike protein. […]

TANAKA Wins Award in Industry of FY2019 FCDIC Honoring System

TOKYO, Sep 10, 2020 – (ACN Newswire) – TANAKA Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka) announced today that TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, has won the “Award in Industry” under the […]